Press Release

Global Digital Pathology Market to Grow with a CAGR of 10.19% through 2028

Increasing integration of AI in healthcare and increasing prevalence of cancer is expected to drive the Global Digital Pathology Market growth in the forecast period, 2024-2028.

According to TechSci Research report, Global Digital Pathology Market - Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028, the Global Digital Pathology Market stood at USD 0.93 billion in 2022 and is anticipated to grow with a CAGR of 10.19%. One of the primary driving factors behind the growth of the global digital pathology market is the increasing prevalence of generic and rapid technological advancements in digital pathology systems. This factor has significantly contributed to the expansion of the digital pathology market over the forecast period. Additionally, the rising incidence of cancer cases plays a crucial role in driving the growth of the digital pathology market. Moreover, the growing prevalence of chronic and cardiovascular diseases acts as an additional factor that boosts the digital pathology market. The utilization of Artificial Intelligence (AI) has also demonstrated its effectiveness in comparison to previous techniques used for identifying and evaluating pathological characteristics. The implementation of AI has expedited and strengthened the diagnostic process, as well as enhanced the success and cost-efficiency of drug discovery. These advancements have greatly propelled the digital pathology market over the forecast year.

Furthermore, digital pathology has played a significant role in companion diagnostics and drug development pipelines, encompassing molecular biology, bio banking, molecular tissue profiling, and tissue microarray analysis. The increasing demand for high-quality tissue samples in tissue-based biomarker research is projected to drive the adoption of digital pathology in the market over the forecast period.

The digital pathology market is driven by several factors, including the increasing number of teleconsultations, the rising adoption of digital pathology to enhance laboratory efficiency, and its expanding application in drug discovery and companion diagnostics. The integration of digital pathology with digital tools, barcoding, specimen tracking, and digital dictation has also contributed to the growing use of digital pathology in disease diagnosis. These integrations have improved the safety, quality, and efficiency of disease diagnoses in pathology laboratories. According to a report published by the World Health Organization (WHO), digital pathology is expected to have significant potential in making routine pathology practice more efficient and accurate by 2022, owing to its ease of use and the ability to work remotely. Additionally, artificial intelligence (AI)-based assistance systems have been employed to enhance image processing in diagnostic sectors, providing clinicians and specialists with quicker and safer judgments in radiology or pathology practices, as reported by Deontics Ltd in September 2022.

The market is also anticipated to be driven by the increasing adoption of telepathology, rising investment in healthcare in developed countries, the market penetration of key manufacturers in developing regions, and a growing focus on drug discovery. For example, in April 2022, GlaxoSmithKline collaborated with PathAl to introduce digital pathology Artificial Intelligence in cancer and Non-alcoholic steatohepatitis (NASH) drug development. Furthermore, the 2022 EU4Health work program has been allocated a budget of more than EUR 835 million (USD 706.41 million) to enhance health systems in Europe, including approximately EUR 77 million (USD 65.14 million) for digital investment. The establishment of the European health data space, aimed at facilitating greater exchange and access to health data across member states, is anticipated to receive funding from the digital strand. These government initiatives, combined with technological advancements in the healthcare IT field and initiatives by key players, are expected to drive the growth of the market over the forecast period. Globally, there has been a growing burden of chronic and infectious diseases, including cardiovascular, cancer, diabetes, influenza, orthopaedic, and neurology disorders. These conditions have had detrimental effects on individuals' physical and mental well-being, leading to disability. According to statistics published by the British Heart Foundation in January 2022, there were approximately 7.6 million people in the United Kingdom affected by cardiovascular disorders (CVDs). The increasing prevalence of cardiovascular diseases has resulted in a higher demand for innovative technologies for diagnosing such conditions, driving market growth.

The integration of digital pathology with digital tools such as barcoding, specimen tracking, and digital dictation has improved the safety, quality, and efficiency of disease diagnosis in pathology laboratories. The digital pathology platform allows for the instant sharing of whole slides among multiple pathologists, enabling collaborative input on cases. For example, in January 2021, Roche launched uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis for breast cancer, using automated digital pathology algorithms with artificial intelligence. These algorithms assist pathologists in making rapid and accurate diagnoses, supporting the determination of the most effective treatment strategies for each patient. Consequently, the utilization of digital pathology for disease diagnosis is expected to grow steadily in the forecast period.

Considering the increasing burden of chronic and infectious diseases and the integration of digital pathology, the disease diagnosis segment is projected to experience significant growth over the forecast period.

Browse over 26 market data Figures spread through 91 Pages and an in-depth TOC on "Global Digital Pathology Market


The Global Digital Pathology Market is segmented into product type, application, end user, regional distribution, and company.

Based on application, the disease diagnosis segment is anticipated to experience rapid growth, driven by the escalating prevalence of chronic illnesses and manufacturers' dedication to developing advanced and swift diagnostic techniques. These techniques aim to facilitate seamless exchange of information between different departments. The adoption of digital technologies plays a vital role in improving the efficiency of disease diagnosis and enhancing therapeutic interventions. For instance, in April 2022, PreciseDx collaborated with The Michael J. Fox Foundation to unveil AI-powered digital pathology technology for early diagnosis of Parkinson's disease, even before severe symptoms manifest in patients.

Based on region, North America segment is expected to grow during the forecast period.  The North American digital pathology market is driven by several key factors. These include the increasing burden of chronic diseases, the adoption of technologies in chronic disease management, investments, product launches, and initiatives by market players. The United States, specifically, is projected to experience significant growth during the study period. The rising prevalence of chronic diseases like cancer and Alzheimer's disease is expected to fuel the demand for digital diagnostics. For example, the American Cancer Society estimated that approximately 236,740 new cases of lung cancer would be diagnosed in the country in 2022. Similarly, kidney cancer is also anticipated to contribute to the burden, with an estimated 79,000 new cases reported in 2022. Moreover, the International Diabetes Federation reported that around 14 million adults in Mexico were living with diabetes in 2021. In Canada, diabetes is one of the major chronic diseases affecting the population, with over 3 million diagnosed cases and 6.1% of adults at a high risk of developing the condition as of August 2021. The substantial burden of cancer is expected to drive the demand for digital pathology, consequently fostering market growth.

Major companies operating in Global Digital Pathology Market are:

  • 3DHISTECH
  • Corista
  • Aiforia Technologies Oy
  • Akoya Biosciences
  • OptraSCAN
  • Glencoe Software
  • QProscia Inc
  • Kanteron Systems
  • Mikroscan Technologies
  • OptraSCAN

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“Digital pathology offers an enhanced viewing experience, thereby improving analysis and reducing diagnostic error rates. These tools also provide service providers with immediate access to previous cases for comparison, facilitating long-term predictive analysis through data storage. Barcoding specimens minimizes the risk of misidentification and eliminates concerns about lost data due to slide breakage. The market growth of digital pathology systems is expected to be driven by increasing technological advancements. For example, according to an article published in the Visceral Medicine Journal in 2021, digital pathology has witnessed technological advancements in artificial intelligence and label-free imaging. The utilization of artificial intelligence in digital pathology is growing in tandem with the development of slide scanners, the abundance of data generated, and the ever-increasing computing power. The growth of the global digital pathology market is primarily driven by the increasing prevalence of cancer, the growing demand for accurate diagnostics, and the development of new digital pathology systems by numerous key players. According to a report published by Medscape, chronic diseases are associated with higher mortality rates. The underlying reason for the advancement of advanced diagnostic solutions is the rising prevalence of cardiovascular disorders. Consequently, as the incidence of chronic and cardiovascular diseases continues to rise, the demand for digital pathology systems is expected to increase, thereby driving the growth of the digital pathology market.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Global Digital Pathology Market By Product Type (Scanners, Software, and Storage & Communication Systems), By Application (Disease Diagnosis, Teleconsultation, Drug Discovery, Training & Education), By End User (Pharmaceutical & Biotechnology Companies, Hospitals and Clinics, Academics Institutes & Research Laboratories), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Digital Pathology Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Digital Pathology Market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Web:  https://www.techsciresearch.com

Relevant News